Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

  141,861,898      
Direct Value   $81,660,525    

Indirect Value

  $12,932,114,466      
Total Shares   142,789,105      
Total Value   $13,013,774,992      


Incyte Corp
 $32,141,876 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634 Incyte Corp
 $32,141,876 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    36   
    6    

     Stock price went up :

    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

Download
  Page 50 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
INCY Incyte Corp Director   –       •       •   2011-12-07 4 B $13.21 $1,915,214 I/I 144,903 11,484,023 2.25 -
INCY Incyte Corp Director   –       •       •   2011-12-08 4 B $13.44 $2,992,186 I/I 222,320 11,706,343 2.25 -
INCY Incyte Corp Director   –       •       •   2011-12-08 4 B $13.44 $80,282 I/I 5,965 336,352 2.25 -
INCY Incyte Corp Director   –       •       •   2011-12-09 4 B $13.19 $2,402,409 I/I 181,201 11,887,544 2.25 -
INCY Incyte Corp Director   –       •       •   2011-12-09 4 B $13.19 $64,462 I/I 4,862 341,214 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2011-12-14 4 B $27.29 $213,613 I/I 7,828 303,264 1.5 -
ADLR Adolor Corp 10% Owner   –       –       •   2011-12-19 4 D $4.25 $791,656 I/I (186,272) 0 0 -
ADLR Adolor Corp 10% Owner   –       –       •   2011-12-19 4 D $4.25 $28,344,687 I/I (6,669,338) 0 0 -
SGEN Seagen Inc Director   –       •       •   2011-12-30 4 OE $6.25 $2,123,675 I/I 339,788 4,966,001 0 -
SGEN Seagen Inc Director   –       •       •   2011-12-30 4 OE $6.25 $309,769 I/I 49,563 450,461 0 -
SGEN Seagen Inc Director   –       •       •   2011-12-30 4 OE $6.25 $2,219,644 I/I 355,143 15,131,223 0 -
SGEN Seagen Inc Director   –       •       •   2011-12-30 4 OE $6.25 $425,038 I/I 68,006 539,130 0 -
GEVA Synageva BioPharma Corp Director   –       •       •   2012-01-05 4 A $25.18 $27,124,526 I/I 1,077,225 5,077,676 0 -
GEVA Synageva BioPharma Corp Director   –       •       •   2012-01-05 4 A $25.18 $732,461 I/I 29,089 135,739 0 -
GEVA Synageva BioPharma Corp Director   –       •       •   2012-01-05 4 A $25.18 $4,723,164 I/I 187,576 1,736,065 0 -
INCY Incyte Corp Director   –       •       •   2012-01-12 4 B $16.21 $142,615 I/I 8,769 349,983 2.25 -
INCY Incyte Corp Director   –       •       •   2012-01-12 4 B $16.21 $5,297,473 I/I 325,728 12,213,272 2.25 -
INCY Incyte Corp Director   –       •       •   2012-01-13 4 B $16.46 $96,794 I/I 5,856 355,839 2.25 -
INCY Incyte Corp Director   –       •       •   2012-01-13 4 B $16.46 $3,595,234 I/I 217,511 12,430,783 2.25 -
RDEA Ardea Biosciences Inc Director   –       •       •   2012-02-01 4 B $17.00 $393,924 I/I 23,172 116,454 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-08 4 B $26.17 $868,267 I/I 33,141 1,339,422 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-08 4 B $26.17 $139,904 I/I 5,340 197,404 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-08 4 B $26.17 $5,294,564 I/I 202,089 7,103,792 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-09 4 B $26.24 $233,174 I/I 8,860 1,348,282 2.25 -
GHDX Genomic Health Inc Director   –       •       •   2012-02-09 4 B $26.24 $38,897 I/I 1,478 198,882 2.25 -

  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50  51   52   53   54   55   56      
  Page 50 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed